BRIEF-Merck designated breakthrough therapy by FDA and gets prime status from EMA for ebola vaccine By: Reuters: Company News July 25, 2016 at 09:18 AM EDT * Merck is responsible for research, development, manufacturing, and regulatory efforts in support of v920 Read More >> Related Stocks: Merck & Co